Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data
Abstract Background Threshold regression, in which time to remission is modelled as a stochastic drift towards a boundary, is an alternative to the proportional hazards survival model and has a clear conceptual mechanism for examining the effects of drug dose. However, for both threshold regression...
Main Authors: | Jennifer Hellier, Richard Emsley, Andrew Pickles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-019-3810-9 |
Similar Items
-
Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
by: Xiao-Pei Wang, et al.
Published: (2016-01-01) -
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
by: Yoshiya Tanaka, et al.
Published: (2019-07-01) -
The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients
by: John M. Stacy, et al.
Published: (2021-08-01) -
Prolonged remission of psoriasis with azathioprine pulse therapy
by: Ramji Gupta
Published: (2015-01-01) -
Verbal memory functioning in recurrent depression during partial remission and remission-Brief report
by: Åsa eHammar, et al.
Published: (2013-10-01)